IPO Zoetis Inc. (ZTS) discovers, develops, manufactures and commercializes animal health medicines and vaccines, with a focus on both livestock and companion animals. Zoetis directly markets their portfolio of more than 300 product lines to livestock producers and veterinarians located in approximately 70 countries across North America, Europe, Africa, Asia, Australia and Latin America. In markets where they do not have a direct commercial presence, they generally contract with distributors that provide logistics and sales and marketing support for their products.
Get an advisory report for this company's Initial Public Offering
View this company's prospectus
No comments:
Post a Comment